Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynda Grine

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
The Journal of Dermatological Treatment|December 15, 2015
Psoriasis: burning down the hostLynda Grine, Jo Lambert
The Journal of Dermatological Treatment|October 6, 2020
Dermatologists on the medical need for therapeutic drug monitoring of biologics in psoriasis: results of a structured surveyLisa Schots, Lynda Grine, Rani Soenen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2015
Dual Inhibition of TNFR1 and IFNAR1 in Imiquimod-Induced Psoriasiform Skin Inflammation in MiceLynda Grine, Lien Dejager, Claude Libert, et al.
Cytokine & Growth Factor Reviews|December 2, 2014
An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17Lynda Grine, Lien Dejager, Claude Libert, et al.
Experimental Dermatology|February 3, 2016
Analysis of telomere length as predictive marker in psoriasis for comorbiditiesEmma Coussens, Lynda Grine, Jessica Bostoen, et al.
Experimental Dermatology|August 24, 2017
Towards the development of a RNAi-based topical treatment for psoriasis: Proof-of-concept in a 3D psoriasis skin modelEline Desmet, Mireille Van Gele, Lynda Grine, et al.
JAMA Dermatology|June 8, 2022
Patient-Relevant Outcomes in Psoriasis: A Systematic ReviewNiels Hilhorst, Elfie Deprez, Nele Pauwels, et al.
JMIR Research Protocols|February 23, 2022
The Effects of Modified Intermittent Fasting in Psoriasis (MANGO): Protocol for a Two-Arm Pilot Randomized Controlled Open Cross-over StudyLynda Grine, Niels Hilhorst, Nathalie Michels, et al.
Microorganisms|March 6, 2021
Gut-Skin Axis: Current Knowledge of the Interrelationship between Microbial Dysbiosis and Skin ConditionsBritta De Pessemier, Lynda Grine, Melanie Debaere, et al.
American Journal of Clinical Dermatology|July 14, 2018
Targeting the IL-23/IL-17 Pathway in Psoriasis: the Search for the Good, the Bad and the UglySofie Mylle, Lynda Grine, Reinhart Speeckaert, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
The Journal of Dermatological Treatment|December 15, 2015
Psoriasis: burning down the hostLynda Grine, Jo Lambert
The Journal of Dermatological Treatment|October 6, 2020
Dermatologists on the medical need for therapeutic drug monitoring of biologics in psoriasis: results of a structured surveyLisa Schots, Lynda Grine, Rani Soenen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2015
Dual Inhibition of TNFR1 and IFNAR1 in Imiquimod-Induced Psoriasiform Skin Inflammation in MiceLynda Grine, Lien Dejager, Claude Libert, et al.
Cytokine & Growth Factor Reviews|December 2, 2014
An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17Lynda Grine, Lien Dejager, Claude Libert, et al.
Experimental Dermatology|February 3, 2016
Analysis of telomere length as predictive marker in psoriasis for comorbiditiesEmma Coussens, Lynda Grine, Jessica Bostoen, et al.
Experimental Dermatology|August 24, 2017
Towards the development of a RNAi-based topical treatment for psoriasis: Proof-of-concept in a 3D psoriasis skin modelEline Desmet, Mireille Van Gele, Lynda Grine, et al.
JAMA Dermatology|June 8, 2022
Patient-Relevant Outcomes in Psoriasis: A Systematic ReviewNiels Hilhorst, Elfie Deprez, Nele Pauwels, et al.
JMIR Research Protocols|February 23, 2022
The Effects of Modified Intermittent Fasting in Psoriasis (MANGO): Protocol for a Two-Arm Pilot Randomized Controlled Open Cross-over StudyLynda Grine, Niels Hilhorst, Nathalie Michels, et al.
Microorganisms|March 6, 2021
Gut-Skin Axis: Current Knowledge of the Interrelationship between Microbial Dysbiosis and Skin ConditionsBritta De Pessemier, Lynda Grine, Melanie Debaere, et al.
American Journal of Clinical Dermatology|July 14, 2018
Targeting the IL-23/IL-17 Pathway in Psoriasis: the Search for the Good, the Bad and the UglySofie Mylle, Lynda Grine, Reinhart Speeckaert, et al.
Pageof 3